Skip to main content

Antibiotic Shortage Resolved

September 28, 2016

The US Food and Drug Administration (FDA) announced the end of the shortage of vancomycin hydrochloride for injection, USP.

Baxter Healthcare, Fresenius Kabi USA, Hospira, Mylan Institutional, and Sagent Pharmaceuticals now all have various presentations available. For a complete listing, click here.

The shortage started in November 2014. In March, several of the companies listed above reported that they had some stock available.


--Stephanie Vaccaro



US Food and Drug Administration. FDA drug shortages. Accessed September 28, 2016.


Back to Top